Stock Comparison
Abbott Laboratories vs Medtronic plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Abbott Laboratories
ABT · New York Stock Exchange
Weighted across the company's segments.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisMedtronic plc
MDT · New York Stock Exchange
Weighted across the company's segments.
Full stock profile
Dive deeper into Medtronic plc's moat claims, evidence, and risks.
View MDT analysisComparison highlights
- Moat score gap: Medtronic plc leads (58 / 100 vs 22 / 100 for Abbott Laboratories).
- Segment focus: Abbott Laboratories has 9 segments (27% in Cardiovascular and Electrophysiology Devices); Medtronic plc has 4 segments (42% in Cardiovascular Portfolio).
- Moat breadth: Abbott Laboratories has 1 moat types across 1 domains; Medtronic plc has 3 across 1.
Primary market context
Abbott Laboratories
Cardiovascular and Electrophysiology Devices
Rhythm management, electrophysiology, heart failure, vascular and structural-heart devices
Global
Hospitals, ambulatory surgery centers and cardiovascular clinicians
Implantable and procedure-based device manufacturer
27%
Medtronic plc
Cardiovascular Portfolio
Cardiovascular medical devices (cardiac rhythm management, electrophysiology/ablation, structural heart, coronary & peripheral vascular)
Global
Hospitals, cath labs, electrophysiologists, cardiologists, cardiac & vascular surgeons
Device OEM + procedure support + remote monitoring software/services
42%
Side-by-side metrics
Moat coverage
Shared moat types
Abbott Laboratories strengths
No unique moat types yet.
Medtronic plc strengths
Segment mix
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Core Laboratory Diagnostics
Oligopoly
Rapid and Molecular Diagnostics
Competitive
Cancer Diagnostics
Competitive
Diabetes Care (CGM and glucose monitoring)
Oligopoly
Cardiovascular and Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
Medtronic plc segments
Full profile >Cardiovascular Portfolio
Oligopoly
Neuroscience Portfolio
Oligopoly
Medical Surgical Portfolio
Competitive
Former Diabetes / MiniMed (separated October 2026)
Oligopoly
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.